Erlotinib 'dosing-to-rash': a phase II intrapatient dose escalation and pharmacologic study of erlotinib in previously treated advanced non-small cell lung cancer
In: British Journal of Cancer, Jg. 105 (2011), Heft 7, S. 938-944
Online
serialPeriodical
Zugriff:
Titel: |
Erlotinib 'dosing-to-rash': a phase II intrapatient dose escalation and pharmacologic study of erlotinib in previously treated advanced non-small cell lung cancer
|
---|---|
Autor/in / Beteiligte Person: | Mita, AC ; Papadopoulos, K ; e Jonge, Maja ; Schwartz, G ; Verweij, Jaap ; Mita, MM ; Ricart, A ; Chu, QC ; Tolcher, AW ; Wood, L ; McCarthy, S ; Hamilton, M ; Iwata, K ; Wacker, B ; Witt, K ; Rowinsky, EK ; Oncology, Medical |
Link: | |
Zeitschrift: | British Journal of Cancer, Jg. 105 (2011), Heft 7, S. 938-944 |
Veröffentlichung: | 2011 |
Medientyp: | serialPeriodical |
ISSN: | 0007-0920 (print) ; 1532-1827 (print) |
DOI: | 10.1038/bjc.2011.332 |
Sonstiges: |
|